| Young J Genau, MD | |
|
7131-39 Frankford Avenue, Philadelphia, PA 19135 | |
| (215) 332-4164 | |
| (215) 332-9638 |
| Full Name | Young J Genau |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 12 Years |
| Location | 7131-39 Frankford Avenue, Philadelphia, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215948344 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Virtua West Jersey Hospitals | Voorhees, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Virtua Medical Group, Pa | 9830222397 | 1226 |
News Archive
Researchers at the Leibniz-Institutes für Wissensmedien and of the Graduate School and Research Network LEAD at the University of Tübingen now found out: Short and intensive arithmetic training strengthens the neuronal connections between brain regions in adults
Bluebeards Original is pleased to announce that it has joined with the Lung Cancer Alliance in the month of November to help raise awareness about lung cancer and lung cancer screening. Throughout the month of November, Bluebeards Original will donate 5% of every purchase made on bluebeardsoriginal.com, while promoting lung cancer awareness on its site and through social media.
ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, is today issuing a business update and its half year results for the six month period ending 30 June, 2009.
Pacifiers may stunt the emotional development of baby boys by robbing them of the opportunity to try on facial expressions during infancy.
pSivida Corp., a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced that the New Drug Application for ILUVIEN for the treatment of chronic Diabetic Macular Edema has been resubmitted to the U.S. Food and Drug Administration (FDA).
› Verified 1 days ago
| Entity Name | Advocare Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770538696 PECOS PAC ID: 3678562188 Enrollment ID: O20040510001217 |
News Archive
Researchers at the Leibniz-Institutes für Wissensmedien and of the Graduate School and Research Network LEAD at the University of Tübingen now found out: Short and intensive arithmetic training strengthens the neuronal connections between brain regions in adults
Bluebeards Original is pleased to announce that it has joined with the Lung Cancer Alliance in the month of November to help raise awareness about lung cancer and lung cancer screening. Throughout the month of November, Bluebeards Original will donate 5% of every purchase made on bluebeardsoriginal.com, while promoting lung cancer awareness on its site and through social media.
ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, is today issuing a business update and its half year results for the six month period ending 30 June, 2009.
Pacifiers may stunt the emotional development of baby boys by robbing them of the opportunity to try on facial expressions during infancy.
pSivida Corp., a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced that the New Drug Application for ILUVIEN for the treatment of chronic Diabetic Macular Edema has been resubmitted to the U.S. Food and Drug Administration (FDA).
› Verified 1 days ago
| Entity Name | Virtua Medical Group, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649226515 PECOS PAC ID: 9830222397 Enrollment ID: O20100804000338 |
News Archive
Researchers at the Leibniz-Institutes für Wissensmedien and of the Graduate School and Research Network LEAD at the University of Tübingen now found out: Short and intensive arithmetic training strengthens the neuronal connections between brain regions in adults
Bluebeards Original is pleased to announce that it has joined with the Lung Cancer Alliance in the month of November to help raise awareness about lung cancer and lung cancer screening. Throughout the month of November, Bluebeards Original will donate 5% of every purchase made on bluebeardsoriginal.com, while promoting lung cancer awareness on its site and through social media.
ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, is today issuing a business update and its half year results for the six month period ending 30 June, 2009.
Pacifiers may stunt the emotional development of baby boys by robbing them of the opportunity to try on facial expressions during infancy.
pSivida Corp., a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced that the New Drug Application for ILUVIEN for the treatment of chronic Diabetic Macular Edema has been resubmitted to the U.S. Food and Drug Administration (FDA).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Young J Genau, MD 301 Lippincott Dr Ste 410, Marlton, NJ 08053-4197 Ph: (856) 355-0340 | Young J Genau, MD 7131-39 Frankford Avenue, Philadelphia, PA 19135 Ph: (215) 332-4164 |
News Archive
Researchers at the Leibniz-Institutes für Wissensmedien and of the Graduate School and Research Network LEAD at the University of Tübingen now found out: Short and intensive arithmetic training strengthens the neuronal connections between brain regions in adults
Bluebeards Original is pleased to announce that it has joined with the Lung Cancer Alliance in the month of November to help raise awareness about lung cancer and lung cancer screening. Throughout the month of November, Bluebeards Original will donate 5% of every purchase made on bluebeardsoriginal.com, while promoting lung cancer awareness on its site and through social media.
ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, is today issuing a business update and its half year results for the six month period ending 30 June, 2009.
Pacifiers may stunt the emotional development of baby boys by robbing them of the opportunity to try on facial expressions during infancy.
pSivida Corp., a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced that the New Drug Application for ILUVIEN for the treatment of chronic Diabetic Macular Edema has been resubmitted to the U.S. Food and Drug Administration (FDA).
› Verified 1 days ago
Dr. Suneil Seetharam, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2301 S Broad St, Philadelphia, PA 19148 Phone: 215-952-9000 | |
Samuel Augustus Hofacker, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 111 S 11th St, Philadelphia, PA 19107 Phone: 215-955-0735 | |
Ms. Mala T Kailasam, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 333 Cottman Ave, Fox Chase Cancer Center, Philadelphia, PA 19111 Phone: 215-728-6900 Fax: 215-214-1425 | |
Dr. Farhan Khan, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4190 City Ave Ste 315, Department Of Surgery, Philadelphia, PA 19131 Phone: 215-871-6942 | |
Furman S Mcdonald, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 700 Spruce Street, Suite 304 Duncan Building, Philadelphia, PA 19106 Phone: 215-829-3521 | |
Daria Viktorovna Madeeva, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3401 Civic Center Blvd, Philadelphia, PA 19104 Phone: 267-961-9282 | |
Dr. Nimesh Patel, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1930 S Broad St, Philadelphia, PA 19145 Phone: 267-570-5200 Fax: 215-279-9219 |